Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

EPIRUS Biopharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Jun 2016 Reuters Investment Profile 12 $20.00

EPRS: Updated Model: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

30 Jun 2016 New Constructs, LLC 10 $25.00

Thomson Reuters Stock Report - EPIRUS Biopharmaceuticals Inc (EPRS-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Jun 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for EPRS

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

26 Jun 2016 ValuEngine, Inc. 11 $25.00

EPIRUS Biopharmaceuticals

25 Jun 2016 S&P Capital IQ Quantitative Report 9 $104.00

EPIRUS BIOPHARMACEUTICALS INC (EPRS=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

25 Jun 2016 Pechala's Reports 2 $25.00

Value Graph: EPIRUS BIOPHARM -- EPRS

24 Jun 2016 Ford Investor Services, Inc. 1 $12.00

Wright Investors Service Comprehensive Report for Epirus Biopharmaceuticals Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

07 Jun 2016 Wright Reports 61 $75.00

Thomson Reuters Stock Report - EPIRUS Biopharmaceuticals Inc (EPRS-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 12 $25.00

Epirus Biopharmaceuticals Inc: Downgraded to Average

29 Mar 2016 Sadif Analytics Prime 3 $10.00